GlaxoSmithKline
GSK
$36.34
Share price
-1.90%
Change (1 day)
-10.99%
Change (1 year)
Categories
GlaxoSmithKline (GSK) - Net assets
Net assets on the balance sheet as of June 2023 : $15.33 B
According to GlaxoSmithKline's latest financial reports the company has $15.33 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
GlaxoSmithKline - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $12.23 B | -57.52% |
| 2021-12-31 | $28.80 B | 1.57% |
| 2020-12-31 | $28.36 B | 17.83% |
| 2019-12-31 | $24.07 B | 416.44% |
| 2018-12-31 | $4.66 B | -1.16% |
| 2017-12-31 | $4.71 B | -23.06% |
| 2016-12-31 | $6.12 B | -53.42% |
| 2015-12-31 | $13.15 B | 71.2% |
| 2014-12-31 | $7.68 B | -40.36% |
| 2013-12-31 | $12.88 B | 18.16% |
| 2012-12-31 | $10.90 B | -20.36% |
| 2011-12-31 | $13.69 B | -8.98% |
| 2010-12-31 | $15.04 B | -13.46% |
| 2009-12-31 | $17.38 B | 42.59% |
| 2008-12-31 | $12.19 B | -38.08% |
| 2007-12-31 | $19.68 B | 3.89% |
| 2006-12-31 | $18.95 B | 45.62% |
| 2005-12-31 | $13.01 B | 14.18% |
| 2004-12-31 | $11.39 B | 9.78% |
| 2003-12-31 | $10.38 B | 10.79% |
| 2002-12-31 | $9.37 B | -12.02% |
| 2001-12-31 | $10.65 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $51.93 B | 238.58% | 🇨🇭 Switzerland |
 Pfizer PFE | $101.23 B | 560.03% | 🇺🇸 USA |
 Sanofi SNY | $79.27 B | 416.88% | 🇫🇷 France |
 Merck MRK | $46.90 B | 205.81% | 🇺🇸 USA |
 AstraZeneca AZN | $37.41 B | 143.94% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $7.70 B | -49.75% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.57 B | -96.24% | 🇺🇸 USA |